Stay updated on INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial
Sign up to get notified when there's something new on the INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial page.

Latest updates to the INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol for the treatment of relapsed or refractory multiple myeloma, including changes to the randomization process and the removal of detailed inclusion and exclusion criteria.SummaryDifference16%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check88 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check102 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial page.